Asymmetric Primaquine and Halogenaniline Fumardiamides as Novel Biologically Active Michael Acceptors.

ABSTRACT: Novel primaquine (PQ) and halogenaniline asymmetric fumardiamides 4a?f, potential Michael acceptors, and their reduced analogues succindiamides 5a?f were prepared by simple three-step reactions: coupling reaction between PQ and mono-ethyl fumarate (1a) or mono-methyl succinate (1b), hydrolysis of PQ-dicarboxylic acid mono-ester conjugates 2a,b to corresponding acids 3a,b, and a coupling reaction with halogenanilines. 1-[bis(Dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU) was used as a coupling reagent along with Hünig's base. Compounds 4 and 5 were evaluated against a panel of bacteria, several Mycobacterium strains, fungi, a set of viruses, and nine different human tumor cell lines. p-Chlorofumardiamide 4d showed significant activity against Staphylococcus aureus,Streptococcus pneumoniae and Acinetobacter baumannii, but also against Candida albicans (minimum inhibitory concentration (MIC) 6.1?12.5 µg/mL). Together with p-fluoro and p-CF? fumardiamides 4b,f, compound 4d showed activity against Mycobacterium marinum and 4b,f against M. tuberculosis. In biofilm eradication assay, most of the bacteria, particularly S. aureus, showed susceptibility to fumardiamides. m-CF? and m-chloroaniline fumardiamides 4e and 4c showed significant antiviral activity against reovirus-1, sindbis virus and Punta Toro virus (EC₅₀ = 3.1?5.5 µM), while 4e was active against coxsackie virus B4 (EC₅₀ = 3.1 µM). m-Fluoro derivative 4a exerted significant cytostatic activity (IC₅₀ = 5.7?31.2 ?M). Acute lymphoblastic leukemia cells were highly susceptible towards m-substituted derivatives 4a,c,e (IC₅₀ = 6.7?8.9 ?M). Biological evaluations revealed that fumardiamides 4 were more active than succindiamides 5 indicating importance of Michael conjugated system.

SUBMITTER: Rajic Z 

PROVIDER: S-EPMC6100582 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature